Author

P. Van der Veken

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1

Frequent Co-Authors

A. A. Fitzgerald· 1 shared A. D'Hoore· 1 shared A. Nasir· 1 shared A. Wolthuis· 1 shared A. Zouzaf· 1 shared B. Verstockt· 1 shared B.-J. Ke· 1 shared C. Breynaert· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. A. Fitzgerald

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Intercellular interaction between FAP fibroblasts and CD150 inflammatory monocytes mediates fibro-stenosis in Crohn's disease

B.-J. Ke, S. Abdurahiman, F. Biscu, G. Dragoni, S. Santhosh, V. De Simone, A. Zouzaf, L. van Baarle, M. Stakenborg, V. Bosakova, Y. Van Rymenant, E. Verhulst, S. Verstockt, G. Bislenghi, A. Wolthuis, , G. Matteoli

The paper identifies intercellular interactions between FAP fibroblasts and CD150 monocytes that drive fibro-stenosis in Crohn's disease and shows TWIST1 inhibition can reduce fibrosis.

bioRxiv · May 4, 2023Immunology

Fibroblast activation protein regulates natural killer cell migration, extravasation and tumor infiltration

A. A. Fitzgerald, R. E. Maynard, E. F. Marcisak, A. Nasir, E. Glasgow, S. Jablonski, P. Van der Veken, G. Pearson, S. E. Eisman, E. M. Mace, E. J. Fertig, L. M. Weiner

This study shows that fibroblast activation protein (FAP) is expressed by human NK cells and promotes their migration, extravasation, and tumor infiltration, suggesting FAP as a target to enhance NK cell-based therapies.

bioRxiv · Feb 3, 2021 · PreprintImmunology